Agency Information Collection Activities: Proposed Collection; Comment Request, 49094-49095 [2018-21171]
Download as PDF
amozie on DSK3GDR082PROD with NOTICES1
49094
Federal Register / Vol. 83, No. 189 / Friday, September 28, 2018 / Notices
vendor into the Board’s contract writing
and invoice payment system. As a result
of the criteria used by the Board to
evaluate proposals, the Solicitation
Package may also include the Past
Performance Data Sheet and Past
Performance Questionnaire (Attachment
I of FR 1400B) if past performance is an
evaluation factor. Typically, if past
performance is considered an evaluation
factor, the vendor is asked to submit
information on up to three previous
contracts whose effort is recent and
relevant to the effort required by the
solicitation.
Solicitations that require the vendor
to process, store, or transmit data from
the Board will contain the Vendor Risk
Management Offeror Questionnaire (FR
1400C). The questionnaire will be
specific to the security controls
surrounding the vendor’s proposed
application that will be used to process,
store, or transmit the data. Security
controls will be defined and prioritized
based on the Federal Information
Security Modernization Act of 2014
(FISMA) and the National Institute of
Standards and Technology (NIST)
Special Publication 800–53 (Security
Controls and Assessment Procedures for
Federal Information Systems and
Organizations). In addition, for
solicitations that have subcontracting
opportunities and are expected to
exceed $100,000 ($300,000 for
construction), a non-covered company
vendor is required to submit a
subcontracting plan in its own format,
with its proposal. Then, if the vendor is
the chosen vendor and awarded a
contract, the vendor is required to
provide the quarterly Subcontracting
Reports (FR 1400D) to the Board, which
shall document the vendor’s
participation achievement on a
cumulative basis. Information from the
Subcontracting Report is used to assist
the Board in fulfilling the requirement
in Section 342(e) of the Dodd-Frank Act
that requires the Board to submit to
Congress an annual report regarding the
fair inclusion of minorities and women
in contracting.
Proposed revisions: To assist the
Board’s competitive vendor solicitation
process, the Board is proposing to revise
the FR 1400 by (1) reformatting and
updating the Solicitation Package,
including the Solicitation, Offer, and
Award Form (SOA), Supplier
Information Form, Past Performance
Data Sheet, and Past Performance
Questionnaire (FR 1400B); (2) adding
the Vendor Risk Management Offeror
Questionnaire (FR 1400C); and (3)
revising the Subcontracting Report (FR
1400D) to improve clarity and gather
specific information in accordance with
VerDate Sep<11>2014
19:22 Sep 27, 2018
Jkt 244001
the Board’s subcontracting goals. Lastly,
the Board proposes to discontinue the
use of the Request for Price Quotation
Form (RFP/RFPQ). The purpose of the
RFPQ form will be absorbed into the FR
1400B.
Legal authorization and
confidentiality: The FR 1400A is
voluntary. For prospective vendors that
decide to submit proposals to the Board,
the FR 1400B, 1400C, and 1400D are
required to obtain a benefit, in order to
be eligible for the award of a contract.
The FR 1400 is authorized pursuant to
sections 10 and 11 of the Federal
Reserve Act (‘‘FRA’’), and section 342(c)
of the Dodd-Frank Wall Street Reform
and Consumer Protection Act (‘‘DoddFrank’’). Sections 10(3) and 11 of the
FRA (12 U.S.C. 243 and 248(l)) grant the
Board full authority to manage its
buildings and its staff. Section 10(4) of
the FRA (12 U.S.C. 244) authorizes the
Board to determine and prescribe the
manner in which its obligations shall be
incurred and its disbursements and
expenses allowed and paid. Therefore,
the Board can solicit proposals and seek
the information in FR 1400 from
prospective vendors.
Additionally, the FR 1400 is
authorized by section 342(c) of DoddFrank (12 U.S.C. 5452(c)), which
requires the Board to develop and
implement standards and procedures for
the review and evaluation of contract
proposals and for hiring service
providers that include a component that
gives consideration to the diversity of a
prospective vendor and the fair
inclusion of women and minorities in
the workforce of such vendor and any
subcontractor.
A vendor generally may request
confidential treatment for information
submitted during the solicitation
process, and the Board will review the
request to determine if the data may be
kept confidential under exemption 4 of
the Freedom of Information Act, which
protects from disclosure trade secrets
and commercial or financial information
(5 U.S.C. 552(b)(4)).
Board of Governors of the Federal Reserve
System, September 24, 2018.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2018–21126 Filed 9–27–18; 8:45 am]
BILLING CODE 6210–01–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10464]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
November 27, 2018.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
SUMMARY:
E:\FR\FM\28SEN1.SGM
28SEN1
Federal Register / Vol. 83, No. 189 / Friday, September 28, 2018 / Notices
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
amozie on DSK3GDR082PROD with NOTICES1
CMS–10464 Agent/Broker Data
Collection in Federally Facilitated
Health Insurance Exchanges
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Title of Information Collection:
Agent/Broker Data Collection in
Federally Facilitated Health Insurance
Exchanges; Type of Information
Collection Request: Revision of a
currently approved collection; Use: The
Patient Protection and Affordable Care
Act, Public Law 111–148, enacted on
March 23, 2010, and the Health Care
and Education Reconciliation Act,
Public Law 111–152, enacted on March
30, 2010 (collectively, ‘‘Affordable Care
Act’’), expands access to health
insurance for individuals and
employees of small businesses through
VerDate Sep<11>2014
19:22 Sep 27, 2018
Jkt 244001
the establishment of new Affordable
Insurance Exchanges (Exchanges), also
called Marketplaces, including the
Small Business Health Options Program
(SHOP). Revised requirements
pertaining to agents/brokers completing
Federally-facilitated Exchange (FFE)
registration are discussed in the final
rule published on February 27, 2015 for
the Patient Protection and Affordable
Care Act; HHS Notice of Benefit and
Payment Parameters for 2016 (CMS–
9944–F). These updated requirements
direct agents/brokers to submit
additional fields related to basic contact
information and National Producer
Number (NPN). Current state licensure
and relevant health lines of authority
(LOA) are then validated using the
National Insurance Producer Registry
(NIPR) database. This ICR serves as the
formal request for renewal and also
includes some of the information
collection requirements from the
previously approved final rule. Form
Number: CMS–10464 (OMB control
number: 0938–1204); Frequency:
Annually; Affected Public: Private
Sector (Business or other for-profits);
Number of Respondents: 52,000;
Number of Responses: 52,000; Total
Annual Hours: 12,480. (For questions
regarding this collection contact
Madeline Pellish at 301–492–4390.)
Dated: September 25, 2018.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2018–21171 Filed 9–27–18; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0333]
Richard M. Fleming; Denial of Hearing;
Final Debarment Order
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or the Agency) is
denying a request for a hearing
submitted by Richard M. Fleming
(Fleming) and is issuing an order under
the Federal Food, Drug, and Cosmetic
Act (FD&C Act) debarring Fleming for
10 years from providing services in any
capacity to a person that has an
approved or pending drug product
application. FDA bases this order on a
finding that Fleming was convicted of
two felonies under Federal law that
SUMMARY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
49095
involved fraud. Additionally, Fleming
has demonstrated a pattern of conduct
sufficient to find that there is reason to
believe that he may violate requirements
under the FD&C Act relating to drug
products. In determining the
appropriateness and period of Fleming’s
debarment, FDA considered the relevant
factors listed in the FD&C Act. Fleming
failed to file with the Agency
information and analyses sufficient to
create a basis for a hearing concerning
this action.
DATES: The order is applicable
September 28, 2018.
ADDRESSES: Any application for
termination of debarment by Fleming
under section 306(d) of the FD&C Act
(application) may be submitted as
follows:
Electronic Submissions
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
An application submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
application will be made public, you are
solely responsible for ensuring that your
application does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
application, that information will be
posted on https://www.regulations.gov.
• If you want to submit an
application with confidential
information that you do not wish to be
made available to the public, submit the
application as a written/paper
submission and in the manner detailed
(see ‘‘Written/Paper Submissions’’ and
’’Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For a written/paper application
submitted to the Dockets Management
Staff, FDA will post your application, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: Your application must
include the Docket No. FDA–2013–N–
E:\FR\FM\28SEN1.SGM
28SEN1
Agencies
[Federal Register Volume 83, Number 189 (Friday, September 28, 2018)]
[Notices]
[Pages 49094-49095]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21171]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10464]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by November 27, 2018.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the
[[Page 49095]]
proposed collection(s) summarized in this notice, you may make your
request using one of following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to [email protected].
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10464 Agent/Broker Data Collection in Federally Facilitated Health
Insurance Exchanges
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Title of Information Collection: Agent/Broker Data Collection in
Federally Facilitated Health Insurance Exchanges; Type of Information
Collection Request: Revision of a currently approved collection; Use:
The Patient Protection and Affordable Care Act, Public Law 111-148,
enacted on March 23, 2010, and the Health Care and Education
Reconciliation Act, Public Law 111-152, enacted on March 30, 2010
(collectively, ``Affordable Care Act''), expands access to health
insurance for individuals and employees of small businesses through the
establishment of new Affordable Insurance Exchanges (Exchanges), also
called Marketplaces, including the Small Business Health Options
Program (SHOP). Revised requirements pertaining to agents/brokers
completing Federally-facilitated Exchange (FFE) registration are
discussed in the final rule published on February 27, 2015 for the
Patient Protection and Affordable Care Act; HHS Notice of Benefit and
Payment Parameters for 2016 (CMS-9944-F). These updated requirements
direct agents/brokers to submit additional fields related to basic
contact information and National Producer Number (NPN). Current state
licensure and relevant health lines of authority (LOA) are then
validated using the National Insurance Producer Registry (NIPR)
database. This ICR serves as the formal request for renewal and also
includes some of the information collection requirements from the
previously approved final rule. Form Number: CMS-10464 (OMB control
number: 0938-1204); Frequency: Annually; Affected Public: Private
Sector (Business or other for-profits); Number of Respondents: 52,000;
Number of Responses: 52,000; Total Annual Hours: 12,480. (For questions
regarding this collection contact Madeline Pellish at 301-492-4390.)
Dated: September 25, 2018.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2018-21171 Filed 9-27-18; 8:45 am]
BILLING CODE 4120-01-P